Target animal safety evaluation of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for cats

The safety profile of NexGard(®) Combo, a novel topical product for cats combining esafoxolaner, eprinomectin and praziquantel, for the treatment and prevention of internal and external parasites, was evaluated in kittens, in two margin-of-safety studies (Studies #1 and #2), and in an oral tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Aradhana, Baker, Christine, Wang, Hailun, Targa, Norba, Pfefferkorn, Anthony, Tielemans, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019570/
https://www.ncbi.nlm.nih.gov/pubmed/33812450
http://dx.doi.org/10.1051/parasite/2021015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019570/
https://www.ncbi.nlm.nih.gov/pubmed/33812450
http://dx.doi.org/10.1051/parasite/2021015

Ejemplares similares